|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1997-8-21
|
|
pubmed:abstractText |
Cardiomyoplasty is a potential therapy for heart failure. Its benefits are attributed to systolic augmentation (dynamic cardiomyoplasty) and prevention of cardiac dilatation (static cardiomyoplasty). To evaluate the static component, we used an artificial membrane for cardiac binding in a canine model of heart failure.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0003-4975
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
64
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
81-5
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9236339-Animals,
pubmed-meshheading:9236339-Antibiotics, Antineoplastic,
pubmed-meshheading:9236339-Cardiac Output, Low,
pubmed-meshheading:9236339-Cardiomyoplasty,
pubmed-meshheading:9236339-Disease Models, Animal,
pubmed-meshheading:9236339-Dogs,
pubmed-meshheading:9236339-Doxorubicin,
pubmed-meshheading:9236339-Hemodynamics,
pubmed-meshheading:9236339-Male,
pubmed-meshheading:9236339-Membranes, Artificial,
pubmed-meshheading:9236339-Time Factors,
pubmed-meshheading:9236339-Ventricular Function, Left
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Cardiac binding in experimental heart failure.
|
|
pubmed:affiliation |
Division of Cardiothoracic Surgery, State University of New York-Health Science Center at Brooklyn 11203, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
